亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

蘇州全輝生物科技有限公司  

醫藥原料及中間體生產銷售

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:劉才伙
  • 電話:0512-66368265
  • 郵件:contact@szqhbio.com
  • 傳真:0512-66368287
  • QQ:1259679610
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > ***左西替利嗪 CAS號:130018-87-0
***左西替利嗪 CAS號:130018-87-0
單價 面議對比
詢價 暫無
發貨 江蘇蘇州市付款后3天內
過期 長期有效
更新 2016-02-17 09:26
 
詳細信息
 

***左西替利嗪

產品名稱:***左西替利嗪

英文名稱:Levocetirizine Dihydrochloride

化學名稱:[2-(4-(對氯苯基芐基)-1-哌嗪基)乙氧基]醋酸****

英文別稱:Aceticacid,[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-,dihydrochloride,(R)-

分子式:C21H25ClN2O3·2HCl
分子量:461.82
CAS
號:
130018-87-0
質量標準:企業標準

性狀:白色至微黃色結晶性粉末

熾灼殘渣:不得超過0.1%

干燥失重:不得超過0.5%

有關物質:單個雜質不得超過0.5%;總雜質不得超過1.0%

含量:不得少于99.0%

包裝:1kg,5kg,10kg;鋁箔袋/紙板桶/按客戶要求包裝

用途:抗過敏類醫藥原料

聯系方式:銷售陳:0512-6636826518994391946QQ1259679610contact@szqhbio.*

©2025 蘇州全輝生物科技有限公司 版權所有   技術支持:化工網   訪問量:4709  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |